COVID-19 Derails SI-BONE’s Record Procedure Trajectory in 1Q20

SI-BONE iFuse Implant

SI-BONE reported 1Q20 orthopedic revenue of USD $16.8 million, +12.2% vs. 1Q19. The company outpaced expectations through mid-March as investments made last year drove record procedure volumes. SI-BONE saw significant declines in the final two weeks of 1Q20, with 300 canceled cases. Procedure volume declined 80% in April compared to the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us